Research priorities for an HIV cure: International AIDS Society Global Scientific Strategy 2021
Steven G. Deeks(University of California, San Francisco), Nancie M. Archin(University of North Carolina at Chapel Hill), Paula M. Cannon(University of Southern California), Simon Collins, R. Brad Jones(Cornell University), Marein A.W.P. de Jong(Aidsfonds), Olivier Lambotte(Inserm), Rosanne Lamplough(International AIDS Society), Thumbi Ndung’u(Africa Health Research Institute), Jeremy Sugarman(Johns Hopkins University), Caroline T. Tiemessen(University of the Witwatersrand), Linos Vandekerckhove, Sharon R. Lewin(The Royal Melbourne Hospital), The International AIDS Society (IAS) Global Scientific Strategy working group(University of California, San Francisco), Core Leadership Group(The Royal Melbourne Hospital), Steven G. Deeks(University of California, San Francisco), Sharon R. Lewin(Peter Doherty Institute), Marein de Jong(Aidsfonds), Working Group 1 (Understanding HIV reservoirs)(Simon Fraser University), Zaza M. Ndhlovu(Sun Yat-sen University), Nicolas Chomont, Zabrina L. Brumme(Treatment Action Group), Kai Deng(Institut Pasteur), Luke D. Jasenosky(National Cancer Institute), Richard Jefferys(Utrecht University), Aurelio Orta‐Resendiz(University of Pennsylvania), Working Group 2 (HIV reservoir measurement)(Merck & Co., Inc., Rahway, NJ, USA (United States)), Frank Mardarelli, Monique Nijhuis(Consejo Nacional de Investigaciones Científicas y Técnicas), Katharine J. Bar(Makerere University), Bonnie J. Howell(Johns Hopkins University), Alex Schneider(University of North Carolina Health Care), Gabriela Turk(Emory University), Rose Nabatanzi(ViiV Healthcare (United Kingdom)), Working Group 3 (Mechanisms of virus control)(Chelsea and Westminster Hospital NHS Foundation Trust), Joel N. Blankson(Fundação Oswaldo Cruz), J. Víctor García(Scripps Research Institute), Mirko Paiardini(Aarhus University Hospital), Jan van Lunzen(Universidade Federal de São Paulo), Christina Antoniadi(Gladstone Institutes), Fernanda Heloise Côrtes(Treatment Action Group), Working Group 4 (Targeting the provirus), Susana Valente(Queen's University), Ole S. Søgaard(MUJHU Research Collaboration), Ricardo Sobhie Diaz(Rockefeller University), Melannie Ott(IrsiCaixa), Richard M. Dunham(National Center for AIDS/STD Control and Prevention,China CDC), Siegfried Schwarze(Imperial College London), Santiago Perez Patrigeon(Gilead Sciences (United States)), Josephine Nabukenya, Working Group 5 (Targeting the immune system)(University of Malawi), Marina Caskey(Fred Hutch Cancer Center), Beatriz Mothe(University of Pennsylvania), Fu Sheng Wang(Joint Clinical Research Centre), Sarah Fidler(Capital Caring), Devi SenGupta(University of Washington), Stephan Dressler(Universiti Sains Malaysia), Mitch Matoga(Johns Hopkins University), Working Group 6 (Cell and gene therapy)(Emory University), Hans‐Peter Kiem(University of Massachusetts Chan Medical School), Pablo Tebas(Chulalongkorn University), Cissy Kityo(ImmunityBio (United States)), Boro Dropulić(Botswana Harvard AIDS Institute Partnership), Michael Louella, Kumitaa Theva Das(La Trobe University), Working Group 7 (Paediatric remission and cure), Deborah Persaud, Ann Chahroudi(Delaney AIDS Research Enterprise), Katherine Luzuriaga(Gender Studies), Thanyawee Puthanakit(Ragon Institute of MGH, MIT and Harvard), Jeffrey T. Safrit(Rakai Health Sciences Program), Gaerolwe Masheto, Working Group 8: (Social, behavioral and ethical aspects of cure), Karine Dubé, Jennifer Power, Jessica Salzwedel, Udom Likhitwonnawut, Jeff Taylor, Oguzhan Latif Nuh, Krista L. Dong, Edward Nelson Kankaka
Cited by 365Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis